Tokyo, Dec. 23 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060158) titled 'A comparative study of gemcitabine plus cisplatin and gemcitabine plus carboplatin in advanced urothelial carcinoma' on Dec. 22.
Study Type:
Observational
Primary Sponsor:
Institute - Tokyo Medical University Hachioji Medical Center
Condition:
Condition - Advanced urothelial carcinoma
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to retrospectively compare the efficacy and prognosis of gemcitabine plus cisplatin and gemcitabine plus carboplatin as first line systemic chemotherapy for patients with advanced urothelial carcinoma, a...